COVID-19 and vitamin D supplementation: Is there any evidence based to reduce the risk?
Several studies and meta-analysis suggest that vitamin D deficiency constitutes a risk factor for acute respiratory infections while supplementation may reduce this risk. Given the current context of the COVID-19 pandemic, the role of vitamin D supplementation in the prevention and improvement of the prognosis of affected patients has been suggested by some studies and refuted by others. Through this article, we report the mechanisms of action and properties of vitamin D, and we discuss the different hypotheses of the involvement of vitamin D in respiratory infections, especially Covid-19 in the light of the most recent published data.
Keywords
How to Cite
Similar Articles
- Simultaneous Determination of Acrylamide, Caffeic Acid, and Caffeine in Commercial Coffee Capsules Using a Rapid and Validated HPLC-DAD Approach
- The Impact of Black Chokeberry (Aronia melanocarpa) on Gut Microbiota and Human Health: Systematic Review and Meta-analysis of Randomized Controlled Trials in Humans
- Understanding Bread Consumption and Waste Patterns in Algeria and Tunisia: Insights into Consumer Practices and Challenges
- Hepatorenal and Cerebral Toxicity Induced by Consumption of Cow Meat Singed with Scrap Tyres: An Experimental Study in a Rat Model
- Editorial introduction to the first issue
- Acid-Induced Gelation of European Eel Protein Isolate Fortified with Fish Oil: Enhancement of Physicochemical, Microstructural and Thermal Properties
- Metabolic syndrome and risk of colorectal adenoma and colorectal cancer: A meta-analysis
- Determination of isoflavones from soy-milk, masoor and mung dal soups in Bangladeshi postmenopausal women
- Modeling of nitrate leaching kinetics during spinach leaf midribs blanching
- Comparative study of total phenolic content and antioxidant proprieties of Quercus fruit: flour and oil
You may also start an advanced similarity search for this article.

NAJFNR is licensed under